The Directory of Pharma Companies and News


Mundipharma International Limited is part of a global network of privately-owned independent associated companies founded in 1956 by doctors, now operating in over 70 countries worldwide. We are focused on developing business partnerships to identify and accelerate meaningful technology across an increasingly diverse portfolio of therapy areas including respiratory, oncology, pain, addiction therapy and inflammatory conditions. Consistent with our entrepreneurial heritage, we like to think we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems.
Category: Pharmaco
Category: Pharmaco

MundiPharma News

2016-12-23\u003cp style=\"text-align: left;\"\u003e\u003cstrong\u003eMundipharma signs new deal with Vectura for global developmen... (PDF)
2016-12-21\u003cp style=\"text-align: left;\"\u003e\u003cstrong\u003eCHMP announces positive opinion for biosimilar rituximab Trux... (PDF)
2016-10-19\u003cp\u003eResults from the NOR-SWITCH study support switch from Remicade® to Remsima® (biosimilar infliximab)\u003c/p... (PDF)
2016-06-30\u003cspan style=\"line-height: 1.4;\"\u003eMundipharma announced an agreement with Orexo granting Mundipharma’s network... (PDF)
2016-06-21Mundipharma announced that Penthrox® (low dose methoxyflurane) has been granted marketing authorisation in France for th... (PDF)
2016-05-16\u003cp\u003eMundipharma and Purdue reach a new deal to in-licence from ESTEVE full global rights and development respon... (PDF)
2015-10-20New study provides insights into potential treatment of severe pain in Parkinson’s disease with prolonged-release oxycod... (PDF)
2015-09-14Mundipharma and Medical Developments International announce a new alliance for the commercialisation of Penthrox\u003csu... (PDF)
2015-02-25Mundipharma launches Remsima®? (infliximab), a new-generation value-based monoclonal antibody, in six European markets (PDF)
2015-01-12Mundipharma, Purdue and Esteve announce a global partnership to drive innovation in pain management (PDF)
2015-01-07Mundipharma receives positive European Commission decision on Targin® (oxycodone/naloxone) for the treatment of Restless... (PDF)
2014-11-10Mundipharma calls for broader stakeholder consensus on pain trial endpoints to meet payer’s requirements (PDF)
2014-10-26Mundipharma receives Positive CHMP Opinion for \u003cem\u003eTargin\u003c/em\u003e\u003csup\u003e®\u003c/sup\u003e (oxyc... (PDF)
2014-09-06Mundipharma announces results of pivotal phase III study for \u003cstrong\u003e\u003cem\u003eflutiform\u003c/em\u003e\u0... (PDF)
2014-08-14Mundipharma secures distribution license for first biosimilar monoclonal antibody \u003cstrong\u003eRemsima\u003c/strong... (PDF)
2014-06-12Burden of asthma revealed in newly published Mundipharma research (PDF)
2013-12-09Emerging data from CLL10 presented at ASH suggests \u003cstrong\u003e\u003cem\u003eLevact\u003c/em\u003e\u003csup\u003e®... (PDF)
2013-11-19New data show efficacy of prolonged release \u003cstrong\u003e\u003cem\u003eTARGIN\u003c/em\u003e\u003csup\u003e®\u003c/... (PDF)
2013-11-02New data presented by Mundipharma highlights a portfolio with cost efficient therapies (PDF)
2013-10-10Future doctors unprepared to manage pain - one of the most common problems they will encounter in clinical practice, exp... (PDF)
2013-09-19Mundipharma commences COPD trial (PDF)
2013-09-10Data show asthma exacerbation rates remain high, even among patients meeting criteria for current clinical control (PDF)
2013-05-24New research identifies link between sub-optimal asthma control across Europe and patient attitudes (PDF)
2013-05-07New survey reveals asthma continues to disrupt millions of lives across Europe (PDF)
2013-02-20Phase 3 data published in The Lancet show bendamustine (\u003cem\u003e\u003cstrong\u003eLevact\u003csup\u003e®\u003c/sup... (PDF)
2012-12-11New results add to growing body of evidence that support bendamustine-rituximab (B-R) combination as first-line treatmen... (PDF)
2012-12-07Rachel Gooch, European Commercial Project Manager, Respiratory at Mundipharma, is named European Marketer of the Year (PDF)
2012-12-03Record number of bendamustine abstracts accepted for presentation at the Annual Meeting of the American Society of Hemat... (PDF)
2012-11-27Mundipharma strengthens oncology portfolio with strategic collaboration for next generation alkylating agents (PDF)
2012-09-20First country in Europe launches \u003cem\u003e\u003cstrong\u003eflutiform \u003csup\u003e®\u003c/sup\u003e \u003c/stron... (PDF)
2012-07-03Positive European Commission decision on\n\u003cstrong\u003e \u003cem\u003eflutiform\u003c/em\u003e \u003c/strong\u003e ... (PDF)
2012-06-03Promising results in search for treatment for patients with indolent non-Hodgkin lymphoma (PDF)
2012-05-05Results from 12 week study support the use of Lodotra in combination with a DMARD for the treatment of RA in adults (PDF)
2012-05-01Mundipharma International appoints Paul Medeiros to head its corporate and business development operations (PDF)
1970-01-01Results from the NOR-SWITCH study support switch from Remicade® to Remsima® (biosimilar infliximab) (PDF)
1970-01-01New data show efficacy of prolonged release \u003cstrong\u003e\u003cem\u003eTARGIN\u003c/em\u003e\u003csup\u003e®\u003c/... (PDF)
1970-01-01Mundipharma commences COPD trial (PDF)
Brought to you by - Latest Jobs in Pharma
Brought to you by - Latest Jobs in Pharma.